Immunoqure AG
Records under this name other than the patents Immunoqure AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 5 of 5 · Back to Immunoqure AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,081,676 | Human ANTI-IL-32 Antibodies and Methods of Making and Using the Same Lapsed on the fee record Ended Sep 25, 2026 · High confidence | Lapsed on the fee record | Ended Sep 25, 2026 | High confidence |
| US 9,957,319 | Method of isolating human antibodies Lapsed on the fee record Ended May 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2026 | From the USPTO record |
| US 10,975,144 | cDNA Encoding A Monoclonal Anti-IL-32 Antibody and Methods for The Production of The Antibody Lapsed on the fee record Ended Apr 13, 2025 · High confidence | Lapsed on the fee record | Ended Apr 13, 2025 | High confidence |
| US 10,875,916 | Nucleic acid molecules encoding monoclonal antibodies specific for IL-17F Lapsed on the fee record Ended Dec 29, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 29, 2024 | From the USPTO record |
| US 9,475,872 | Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F Lapsed on the fee record Ended Oct 25, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 25, 2024 | From the USPTO record |